165 related articles for article (PubMed ID: 21412406)
1. Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1.
Deng X; Yang Q; Kwiatkowski N; Sim T; McDermott U; Settleman JE; Lee JD; Gray NS
ACS Med Chem Lett; 2011 Mar; 2(3):195-200. PubMed ID: 21412406
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.
Deng X; Elkins JM; Zhang J; Yang Q; Erazo T; Gomez N; Choi HG; Wang J; Dzamko N; Lee JD; Sim T; Kim N; Alessi DR; Lizcano JM; Knapp S; Gray NS
Eur J Med Chem; 2013; 70():758-67. PubMed ID: 24239623
[TBL] [Abstract][Full Text] [Related]
3. Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation.
Cameron SJ; Malik S; Akaike M; Lerner-Marmarosh N; Yan C; Lee JD; Abe J; Yang J
J Biol Chem; 2003 May; 278(20):18682-8. PubMed ID: 12637502
[TBL] [Abstract][Full Text] [Related]
4. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
[TBL] [Abstract][Full Text] [Related]
5. Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains.
Wang J; Erazo T; Ferguson FM; Buckley DL; Gomez N; Muñoz-Guardiola P; Diéguez-Martínez N; Deng X; Hao M; Massefski W; Fedorov O; Offei-Addo NK; Park PM; Dai L; DiBona A; Becht K; Kim ND; McKeown MR; Roberts JM; Zhang J; Sim T; Alessi DR; Bradner JE; Lizcano JM; Blacklow SC; Qi J; Xu X; Gray NS
ACS Chem Biol; 2018 Sep; 13(9):2438-2448. PubMed ID: 30102854
[TBL] [Abstract][Full Text] [Related]
6. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
Kato Y; Kravchenko VV; Tapping RI; Han J; Ulevitch RJ; Lee JD
EMBO J; 1997 Dec; 16(23):7054-66. PubMed ID: 9384584
[TBL] [Abstract][Full Text] [Related]
7. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor.
Kato Y; Tapping RI; Huang S; Watson MH; Ulevitch RJ; Lee JD
Nature; 1998 Oct; 395(6703):713-6. PubMed ID: 9790194
[TBL] [Abstract][Full Text] [Related]
8. Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration.
Izawa Y; Yoshizumi M; Ishizawa K; Fujita Y; Kondo S; Kagami S; Kawazoe K; Tsuchiya K; Tomita S; Tamaki T
Hypertens Res; 2007 Nov; 30(11):1107-17. PubMed ID: 18250560
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor.
Rewcastle GW; Bridges AJ; Fry DW; Rubin JR; Denny WA
J Med Chem; 1997 Jun; 40(12):1820-6. PubMed ID: 9191958
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3beta binds to big mitogen-activated protein kinase 1 (BMK1/ERK5) and regulates BMK1 function.
Zheng Q; Yin G; Yan C; Cavet M; Berk BC
J Biol Chem; 2004 Mar; 279(10):8787-91. PubMed ID: 14679215
[TBL] [Abstract][Full Text] [Related]
11. BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha.
Pi X; Garin G; Xie L; Zheng Q; Wei H; Abe J; Yan C; Berk BC
Circ Res; 2005 Jun; 96(11):1145-51. PubMed ID: 15879308
[TBL] [Abstract][Full Text] [Related]
12. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis.
Pi X; Yan C; Berk BC
Circ Res; 2004 Feb; 94(3):362-9. PubMed ID: 14670836
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors.
De Clercq DJH; Heppner DE; To C; Jang J; Park E; Yun CH; Mushajiang M; Shin BH; Gero TW; Scott DA; Jänne PA; Eck MJ; Gray NS
ACS Med Chem Lett; 2019 Nov; 10(11):1549-1553. PubMed ID: 31749909
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults.
Suzaki Y; Yoshizumi M; Kagami S; Koyama AH; Taketani Y; Houchi H; Tsuchiya K; Takeda E; Tamaki T
J Biol Chem; 2002 Mar; 277(11):9614-21. PubMed ID: 11782488
[TBL] [Abstract][Full Text] [Related]
15. Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium.
Yan C; Takahashi M; Okuda M; Lee JD; Berk BC
J Biol Chem; 1999 Jan; 274(1):143-50. PubMed ID: 9867822
[TBL] [Abstract][Full Text] [Related]
16. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions.
Suzaki Y; Yoshizumi M; Kagami S; Nishiyama A; Ozawa Y; Kyaw M; Izawa Y; Kanematsu Y; Tsuchiya K; Tamaki T
Kidney Int; 2004 May; 65(5):1749-60. PubMed ID: 15086914
[TBL] [Abstract][Full Text] [Related]
17. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway.
Chao TH; Hayashi M; Tapping RI; Kato Y; Lee JD
J Biol Chem; 1999 Dec; 274(51):36035-8. PubMed ID: 10593883
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation.
Ishizawa K; Izawa Y; Ito H; Miki C; Miyata K; Fujita Y; Kanematsu Y; Tsuchiya K; Tamaki T; Nishiyama A; Yoshizumi M
Hypertension; 2005 Oct; 46(4):1046-52. PubMed ID: 16087789
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6
Ferguson FM; Liu Y; Harshbarger W; Huang L; Wang J; Deng X; Capuzzi SJ; Muratov EN; Tropsha A; Muthuswamy S; Westover KD; Gray NS
J Med Chem; 2020 Jul; 63(14):7817-7826. PubMed ID: 32530623
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.
Rewcastle GW; Palmer BD; Thompson AM; Bridges AJ; Cody DR; Zhou H; Fry DW; McMichael A; Denny WA
J Med Chem; 1996 Apr; 39(9):1823-35. PubMed ID: 8627606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
